Acute Pancreatitis after Therapy with GABARAN

Research Article

Manuela Stoicescu

Abstract

The main objective of this clinical-case-presentation is to attract attention that the therapy with Gabaran in high dosage and per long period of time without a careful control of function of pancreas (common dosage of amilasemia and amilasuria level) can develop unexpected severe acute pancreatitis and may put the patient’s life in danger.

Relevant Publications in Journal of Developing Drugs